or Try an Advanced Search...

    ETF Components for BIS - ProShares UltraShort Nasdaq Biotechnology


    Below is a list of stocks held by this ETF. We only list holdings in the same market. If this is a global ETF, there may be additional components other than those listed here.

    Holdings

    Symbol Grade Price % Change Allocation
    AMGN D 1.60 8.14
    GILD C 0.48 7.41
    VRTX F 0.13 7.21
    BIIB F -0.07 6.12
    ILMN D 2.30 5.67
    REGN F -0.87 4.13
    INCY C 1.89 2.09
    BMRN D 1.28 1.91
    ALNY D -0.77 1.60
    VTRS A 0.91 1.35
    SNY F 0.63 1.29
    NBIX C 0.52 1.16
    SRPT D 3.38 1.15
    NVCR C 3.74 1.10
    JAZZ B 1.25 1.03
    TECH D 0.32 1.02
    IONS F 0.21 1.02
    GH B 5.39 0.96
    AMRN F 4.52 0.85
    MRNA F 7.48 0.83
    BGNE D -2.08 0.83
    ACAD D 1.17 0.81
    ASND D 5.85 0.77
    EXEL B 2.24 0.73
    ARWR F 1.42 0.65
    BLUE F 17.52 0.65
    BBIO F 0.77 0.51
    ALLK D -3.34 0.49
    UTHR C 1.51 0.49
    NKTR F 3.96 0.48
    SAGE F 6.60 0.48
    BPMC C -2.56 0.48
    FGEN D 2.12 0.47
    AGIO C 0.25 0.43
    CRSP D 3.43 0.42
    RARE D 2.65 0.42
    ADPT C 7.32 0.42
    MEDP D -1.19 0.40
    PTCT B 0.79 0.40
    ARGX A 1.54 0.40
    AXSM B 0.50 0.38
    ALLO F 4.74 0.37
    GRFS C 1.87 0.36
    IOVA F 3.76 0.36
    ALKS B 3.90 0.36
    KOD C 4.92 0.35
    HALO F 7.22 0.35
    QURE D -1.11 0.35
    FOLD F 1.68 0.32
    APLS D 10.88 0.31
    XNCR B 3.78 0.26
    MYGN F 2.45 0.26
    DNLI D 1.94 0.26
    ZLAB C 2.84 0.24
    IRWD F 2.99 0.24
    ARVN D 2.99 0.24
    INSM C -0.89 0.23
    FATE F 10.63 0.23
    PCRX C 0.98 0.22
    GLPG D 7.57 0.22
    ITCI C 0.28 0.21
    RGNX F 4.47 0.21
    ESPR C 2.02 0.19
    EDIT F 2.95 0.19
    LGND B 2.27 0.19
    INVA D 0.47 0.18
    VCYT B 1.67 0.18
    ALEC F 4.79 0.18
    TBPH C -1.46 0.17
    YMAB F 3.07 0.16
    CHRS D -0.91 0.16
    HCM D -1.81 0.15
    SUPN C 1.12 0.15

    Represented by ETF Holdings

    Keywords: Biopharmaceutical Biotechnology Medicine Cancer Life Sciences Clinical Development Biology Pain Immunology Infectious Diseases S&P 500 Disease Genetics Immune System Inflammation Nasdaq 100 Organ Systems Cholesterol Monoclonal Antibodies Monoclonal Antibody
    Industries: Biotechnology Drug Manufacturers - Major Diagnostics & Research Drug Manufacturers - Specialty & Generic Medical Instruments & Supplies

    Recent News for ProShares UltraShort Nasdaq Biotechnology & its Holdings

    Date Stock Title
    Nov 23 TECH "I Knew If I Bought a Sink": What Does Elon Musk's Cryptic Tweet Mean?
    Nov 23 TECH Judge Rejects SEC Bid to Penalize Musk Over Missed Deposition
    Nov 23 INCY What Moved Markets This Week
    Nov 23 VRTX 3 Monster Stocks in the Making
    Nov 23 TECH Jensen Huang's Nvidia Fast-Tracks Samsung's AI Memory Certification As AI Giant Looks To Catch Up To Demand
    Nov 23 TECH Elon Musk's SpaceX Secures New Moon Mission Contract After Starship's Successful 6th Test Flight
    Nov 23 TECH Volkswagen's Affordable ID.2 EV Set For 2025 Launch, SUV Variant To Follow: 'Stable And Likable With Our Secret Sauce'
    Nov 23 TECH Meta Faces Multibillion-Dollar Lawsuit As Supreme Court Dismisses Appeal In Cambridge Analytica Data Scandal
    Nov 23 BBIO Attruby™ (acoramidis), a Near Complete TTR Stabilizer (≥90%), approved by FDA to Reduce Cardiovascular Death and Cardiovascular-related Hospitalization in ATTR-CM Patients
    Nov 22 TECH Wall Street Rebounds Without Its AI Darling's Boost, King Dollar Maintains Dominance While Bitcoin Defies Gravity: This Week In The Markets
    Nov 22 MRNA Jefferies says market nears short term “peak RFK negativity", Vaccine makers up
    Nov 22 GH Guardant Health (GH) Set To Dominate The Growing Liquid Biopsy Market
    Nov 22 MRNA Goldman Sachs: Moderna, Inc. (NASDAQ:MRNA) Is A Top Growth Investor Stock
    Nov 22 XNCR Xencor: Plamotamab NHL Data Leads To RA Program Advancement
    Nov 22 MRNA Moderna Stock Jumps Following Bullish Sales View at Healthcare Conference
    Nov 22 SRPT High Growth Tech Stocks to Watch in November 2024
    Nov 22 SNY Sanofi plans to change hospital drug-discount program
    Nov 22 MRNA Moderna up 8% as Jefferies says market is close to 'peak RFK negativity'
    Nov 22 HALO Halozyme Withdraws Evotec Bid After Rebuff, Reaffirms Strong Growth Outlook
    Nov 22 HALO Halozyme Therapeutics (HALO) Upgraded to Buy: Here's Why
    The investment seeks daily investment results that correspond to two times the inverse (-2x) of the daily performance of the Nasdaq Biotechnology Index®. The fund invests in derivatives that ProShare Advisors believes, in combination, should have similar daily return characteristics as two times the inverse (-2x) of the daily return of the index. The index is a modified capitalization weighted index that includes securities of NASDAQ listed companies that are classified as either biotechnology or pharmaceutical according to the Industry Classification Benchmark ("ICB") which also meet other eligibility criteria determined by NASDAQ. It is non-diversified.
    Exchange Traded Fund ETF Exchange Traded Funds Biotechnology Leveraged ETF Ultra ETF Inverse ETF Bear Market ETF Industry Classification Nasdaq Biotechnology Index Nasdaq Biotech Nasdaq Biotechnology Total Return Index
    Back to the Main BIS Page...